Experic

Experic

Is this your company? Claim your profile to update info and connect with investors.
Claim profile

Private Company

Total funding raised: $25M

Overview

Experic is a specialized CDMO focusing on the challenging niche of powder-based drug products, particularly for inhalation delivery. Its core expertise lies in process development, clinical and commercial manufacturing, and comprehensive clinical trial supply services including packaging, labeling, storage, and global logistics. With facilities in the US and EU, Experic is positioned to support global pharmaceutical and biotech clients through all stages of development, from clinical trials to commercialization. The company emphasizes a collaborative approach and technical proficiency in handling potent and low-dose APIs.

Drug Delivery

Technology Platform

Specialized expertise in powder science and engineering, with a focus on Dry Powder Inhalation (DPI) formulation, process development, and manufacturing for potent and low-dose APIs. Capabilities include tailored equipment design and comprehensive clinical trial packaging/storage systems.

Funding History

1
Total raised:$25M
Series A$25M

Opportunities

Experic is positioned to capitalize on the growing demand for specialized CDMO services in complex drug delivery, particularly Dry Powder Inhalation (DPI).
Its strategic EU expansion in Ireland provides a direct gateway to serve the European clinical trial market, offering integrated storage, packaging, and distribution services.

Risk Factors

Key risks include intense competition from both large full-service CDMOs and niche specialists, operational risks related to cGMP compliance and supply chain integrity, and dependency on the biopharma R&D funding cycle, particularly for inhalation therapies.

Competitive Landscape

Experic competes in a crowded CDMO market, differentiating itself as a specialist in powder handling and inhalation. It faces competition from large players like Lonza and Catalent, as well as focused inhalation experts like Hovione. Its success hinges on superior technical expertise and personalized service in its niche.